BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 10098431)

  • 21. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy.
    Tan LT; Jones B; Green JA; Kingston RE; Clark PI
    Br J Radiol; 1996 Feb; 69(818):165-71. PubMed ID: 8785646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: a retrospective analysis of 556 patients from India.
    Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Ghoshal S; Kumar V; Kapoor R
    Radiother Oncol; 2006 May; 79(2):142-6. PubMed ID: 16677730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
    Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
    Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix.
    Kavanagh BD; Gieschen HL; Schmidt-Ullrich RK; Arthur D; Zwicker R; Kaufman N; Goplerud DR; Segreti EM; West RJ
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):561-8. PubMed ID: 9231680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of tumor regression rate of uterine cervical squamous cell carcinoma during external beam and intracavitary radiotherapy.
    Ohara K; Tanaka YO; Oki A; Okamoto Y; Satoh T; Matsumoto K; Yoshikawa H
    Radiat Med; 2008 Nov; 26(9):526-32. PubMed ID: 19030960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsed-dose-rate vs. high-dose-rate intracavitary radiotherapy for locally advanced carcinoma of cervix: A prospective randomized study.
    Kumar P; Sharma DN; Kumar S; Gandhi AK; Rath GK; Julka PK
    Brachytherapy; 2016; 15(3):327-332. PubMed ID: 26996595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
    Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
    Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: an audit from India.
    Saibishkumar EP; Patel FD; Sharma SC
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):30-7. PubMed ID: 16477917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
    Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
    Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
    Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix.
    Eifel PJ; Morris M; Wharton JT; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):9-16. PubMed ID: 8175451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of the combination of external-beam and high-dose-rate intracavitary irradiation for patients with cervical carcinoma.
    Kataoka M; Kawamura M; Nishiyama Y; Hamada K; Hamamoto K; Matsu-Ura S
    Gynecol Oncol; 1992 Jan; 44(1):48-52. PubMed ID: 1730425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix.
    Chao KS; Williamson JF; Grigsby PW; Perez CA
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):397-403. PubMed ID: 9457827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.